Sector rotation brief
Price target moves

B of A Securities Adjusts Healthcare Targets as Energy Sector Faces Trims

B of A Securities led the latest round of price target revisions as of July 12, 2026, delivering a series of upward adjustments across the healthcare and consumer staples sectors. The firm moved to lift its target on KO from $90 to $95, while simultaneously bolstering its outlook for several key players in the medical space, including LLY, JNJ, and ABBV.

Revisions this week

The activity was heavily concentrated on July 10, reflecting a flurry of adjustments from major houses. Beyond the B of A Healthcare spree, UBS took a constructive stance on the Real Estate sector, nudging PSA from $314 to $326 and EXR from $158 to $163. Meanwhile, Evercore ISI Group focused on Financials and Materials, notably raising BLK to $1145 and LIN to $525.

On the downside, the Energy sector saw persistent pressure. Range Resources (RRC) faced multiple downward revisions from UBS, Truist Securities, and Stephens & Co., dragging its consensus target lower. Similarly, PepsiCo (PEP) endured a wave of caution, with Barclays, Jefferies, TD Cowen, and Morgan Stanley all lowering their respective price targets.

Ticker Firm Dir Prior → Current
MSFT Argus Research Down $620 → $510
ABBV B of A Securities Up $234 → $276
CSX JP Morgan Up $48 → $56
PEP Morgan Stanley Down $180 → $160

What to notice

One outlier in the recent data is the significant contraction in the target for MSFT, which Argus Research slashed from $620 to $510. This stands in stark contrast to the moderate, incremental moves seen across other sectors like Industrials or Financials. While many analysts are fine-tuning their numbers by a few percentage points, this $110 shift suggests a notable re-evaluation of valuation models for the tech giant.

Sector divergence in focus

The contrast between the Healthcare upgrades and the Energy downgrades highlights a growing bifurcation in how analysts view defensive versus cyclical assets. While B of A Securities is clearly signaling confidence in the pharmaceutical pipeline, the downward pressure on energy names like RRC, APA, and SLB suggests a more guarded outlook on commodity-exposed firms. You can track these broader market shifts in detail on the moves page.

Figures reflect our data build as of July 12, 2026. Not investment advice.